Ashland Global Holdings Inc. ASH NYSE · Basic materials · United States
$75.58 -1.16% -$0.89
Summary
41 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 15 USD is left as free cash.
- It has raised its dividend 7 years in a row.
What to watch
- Earnings per share fell by 70% a year over the last 3 years.
- It pays out more in dividends than it earns: 1,912% of profit.
- The share price is above the Bulios Fair Price.
- It missed profit estimates 6 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 865.3 USD for 1 USD of yearly profit. Over the last five years it was 209.3 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 2.5% a year over 5 years. Over the last 3 years it fell by 5.3% a year. For the next fiscal year analysts expect revenue to grow by 3.8%. Earnings per share fell by 70% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 70 USD
- Research and development 3.0 USD
- Sales and administration 22 USD
- Taxes and other 5.3 USD
- Net profit 0.2 USD
Net profit, industry median (Chemicals - Specialty) 6.1 USD
Out of every 100 USD of revenue, 0.2 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 2.21%
- Paid out of profit
- 1,912%
- Raised in a row
- 7 years
You receive $1.67 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 9
- Sell 0
Today's price within the analysts' price targets
The average target of $78.29 is 3.6% above today's price. 64% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Specialty Additives 33%
- Life Sciences 32%
- Personal Care And Household 26%
- Intermediates And Solvents 9.2%
By region
- Non-US 70%
- UNITED STATES 30%
Specialty Additives brings in 33% of revenue.
Segments in detail